SuperScript™ III First-Strand Synthesis SuperMix for qRT-PCR
SuperScript™ III First-Strand Synthesis SuperMix for qRT-PCR
Invitrogen™

SuperScript™ III First-Strand Synthesis SuperMix for qRT-PCR

™ QRT-PCR用SuperScript III第一鎖合成SuperMix™は、SuperScript III Reverse Transcriptaseの高温処理能力を、リアルタイム定量的RT-PCR(qRT-PCR)で使用する第一鎖cDNAの合成に最適化されたSuperMixフォーマットで提供します詳細を見る
製品番号(カタログ番号)反応数
11752250250反応
1175205050反応
製品番号(カタログ番号) 11752250
価格(JPY)
331,300
Each
お問い合わせください ›
反応数:
250反応
一括またはカスタム形式をリクエストする
™ QRT-PCR用SuperScript III第一鎖合成SuperMix™は、SuperScript III Reverse Transcriptaseの高温処理能力を、リアルタイム定量的RT-PCR(qRT-PCR)で使用する第一鎖cDNAの合成に最適化されたSuperMixフォーマットで提供します。2X反応ミックスと酵素ミックスの2つのチューブを使用するだけで、時間をかけずに簡単に反応させることができます。

酵素ミックス
RT酵素ミックスに含まれるSuperScript™ III Reverse Transcriptaseは、RNase H活性を低下させ、熱安定性を向上させるように設計されたM-MLV RTの一種です。この酵素は42~60℃の温度範囲でcDNA合成を行うために使用でき、他の酵素よりも高い特異性やcDNAの収量が得られ、完全長産物の量も他の逆転写酵素より多くなります。SuperScript™ III RTはリボソームRNAや転移RNAによって大きく阻害されないため、全RNAからのcDNAの合成に使用できます。RNaseOUT™組み換えリボヌクレアーゼ阻害剤(酵素ミックスに含まれる)は、RNA調製時のリボヌクレアーゼの混入によるターゲットRNAの分解を防ぐRNase阻害タンパク質です。

反応ミックス
2X RT反応ミックスには、qRT-PCR 用に最適化されたバッファー処方にオリゴ(dT)20、ランダムヘキサマー、MgCl 2、dNTPが含まれます。大腸菌RNase H は、第一鎖合成後のcDNA:RNAハイブリッド分子からRNAテンプレートを除去するために、キットに別のチューブとして用意されています。これはqRT-PCRの感度を向上させることが示されています。

SuperScript™ III第一鎖合成SuperMixの使用
このSuperMix製剤は、qRT-PCRにおいて10コピー以下の標的遺伝子の定量に使用できます。この幅広いダイナミックレンジにより、最大1 µgのトータルRNAから高コピーmRNAを正確に定量できます。試薬は、各20 µLで50または250回の増幅反応分提供されています。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
最終産物タイプcDNA(ファーストストランド)
フォーマットマスターミックス
反応数250反応
最適反応温度50℃
数量250反応
反応形態マスターミックス
試薬タイプ逆転写反応試薬
逆転写酵素SuperScript™ III
出荷条件ドライアイス
原料RNA
技術Reverse Transcription
検出法リアルタイムPCR
使用対象(アプリケーション)Real Time PCR (qPCR)
GC-Rich PCR Performance
反応速度スタンダード
Unit SizeEach
組成および保存条件
SuperScript™IIIファーストストランド合成SuperMix、qRT-PCR用には、以下が付属します。
•2X RT反応ミックス(2 × 1.25 mL、オリゴ(dT)20、ランダムヘキサマー、MgCl2、dNTPsを含む)
• RT酵素ミックス(500 µL、SuperScript™ III RTおよびRNaseOUT™組み換えリボヌクレアーゼ阻害剤を含む)
• 大腸菌RNase(250 µL)

20 µL反応量に基づく250反応に十分な試薬。-20℃で保存

よくあるご質問(FAQ)

How long can I store the cDNA from my reverse transcription step?

You can store your cDNA at 2-6 degrees C for up to 24 hours. For long-term storage, store the cDNA at -15 to -25 degrees C and add EDTA to a final concentration of 1 mM to prevent degradation.

How can I remove genomic DNA contamination from my sample prior to performing RT-PCR?

If amplification products are generated in the control tube/well that contains no reverse transcriptase (i.e., the no-RT control), it may be necessary to eliminate residual genomic DNA from the RNA sample. Use the following protocol to remove genomic DNA from the total RNA preparation.Random primers are the best choice for degraded RNA, RNA with heavy secondary structure, non-polyadenylated RNA, or prokaryotic RNA. It is recommended only for two-step RT-PCR, and typically gives the highest yields, although the cDNA may not necessarily be full length. Oligo(dT) primers are good to use when trying to recover full-length cDNA from 2-step RT-PCR. The reaction is influenced by secondary structure and RNA quality. Gene specific primers should be used for very specific, mainly one-step RT-PCR reactions. Random primers are the best choice for degraded RNA, RNA with heavy secondary structure, non-polyadenylated RNA, or prokaryotic RNA. It is recommended only for two-step RT-PCR, and typically gives the highest yields, although the cDNA may not necessarily be full length. Oligo(dT) primers are good to use when trying to recover full-length cDNA from 2-step RT-PCR. The reaction is influenced by secondary structure and RNA quality. Gene specific primers should be used for very specific, mainly one-step RT-PCR reactions.

Add the following to an autoclaved 0.5 mL microcentrifuge tube on ice:
1.Total RNA, ideally, less than or equal to 1 µg. (See Note 1 below.)
2.1.0 µL of 10X DNase buffer (200 mM Tris, pH 8.3, 500 mM KCl, 20 mM MgCl2).
3.0.1 U-3.0 U of DNase I (RNase-free, Cat. No. 18047019) or 1.0 U Dnase I, Amplification Grade (Cat. No. 18068015. (See Note 2 below.)
4.Bring volume up to 10 µL with DEPC-treated water.
5.Incubate at room temperature for 15 min. (See Note 3 below.)
6.Terminate the reaction by adding 1 µL 25 mM EDTA and heat 10 min at 65 degrees C. (See Note 4 below.)
7.Place on ice for 1 minute.
8.Collect by brief centrifugation. This mixture can be used directly for reverse transcription.

Please note the following:
1.To work with higher quantities of RNA, scale up the entire reaction linearly. Do not exceed 2 µg RNA in the 10 µL reaction. More RNA will increase the viscosity of the solution and prevent the DNAse I from diffusing and finding the DNA.
2.DNAse I, Amplification Grade has been extensively purified to remove trace ribonuclease activities commonly associated with other "RNAse-free" enzyme preparations and does not require the addition of placental RNAse inhibitor.
3.It is important not to exceed the 15 minute incubation time or the room temperature incubation. Higher temperatures and longer times could lead to Mg2+-dependent hydrolysis of the RNA.
4.This procedure requires careful pipetting of all solutions so that the concentration of divalent metal cation (Mg2+) is controlled.
5.Because the DNAse I must be heated to 65 degrees C to inactivate the enzyme, the concentration of free divalent metal ions must be low enough (less than 1 mM) after addition of the EDTA to prevent chemical hydrolysis of the RNA. See references below.
After the addition of EDTA, there is an approximately 1:1 molar ratio of Mg2+ :EDTA. EDTA chelates Mg2+ molecules on a 1:1 molar basis. Therefore, this RNA can be directly used in a reverse transcription reaction. First-strand reverse transcription buffers typically result in a final concentration of 2.5 mM Mg2+. If the reverse transcription buffer does not contain MgCl2, add it to the reaction at a final concentration of 2.5 mM. This results in a net final concentration of approximately 2.25 to 2.5 mM MgCl2.

References on RNA hydrolysis:
Molekulyarnaya Biologiya (1987) 21:1235-1241.
References on the mechanism of hydrolysis by other cations:
Eichorn GL and Butzov JY (1965) Biopolymers 3:79.
Butzov JY and Eichorn GL (1965) Biopolymers 3:95.
Farkas WR (1968) Biochim Biophys Acta 155:401.
The authors of the first paper express the opinion that the mechanism of the nonspecific hydrolysis by cations which proceeds through 2',3' cyclic phosphate formation is similar to that of specific hydrolysis such as RNA splicing.

How much RNA should be employed for first-strand cDNA synthesis?

The amount of RNA template for a cDNA synthesis is highly flexible and depends upon the amount of sample available and an individual's need. In general, 1 µg total RNA is used in a typical 20-µL RT reaction.

Find additional tips, troubleshooting help, and resources within ourReverse Transcription and RACE Support Center.

Should I treat the cDNA with RNase H prior to downstream processing?

Some feel that the RNA in the RNA:DNA duplex after reverse transcription will inhibit PCR primers from annealing and amplifying the cDNA. The RNA is still present when using RNase H-mutant RTs. RNase H frees the cDNA from the RNA. On the other hand, some feel that the 95 degrees C denaturing step will cause the RNA primers to fall off the DNA and therefore RNase H treatment is not necessary. Therefore, this step is optional. For cloning of larger fragments, RNase H treatment can be beneficial.

What percentage of RNA is converted to cDNA when performing reverse transcription?

This depends highly on the quality of the sample. mRNA itself makes up 1-5% of total RNA. Depending on the primer and enzyme used, reverse transcription can covert >70% of that into cDNA.

Find additional tips, troubleshooting help, and resources within our Reverse Transcription and RACE Support Center.

引用および参考文献 (3)

引用および参考文献
Abstract
Simvastatin downregulates the expression of hepcidin and erythropoietin in HepG2 cells.
Authors:Chang CC, Chiu PF, Chen HL, Chang TL, Chang YJ, Huang CH
Journal:Hemodial Int
PubMed ID:22716163
'Statin therapy may improve responsiveness to erythropoietin-stimulating agents in patients with end-stage renal disease. Although statins increase hepatic iron uptake and storage capacity in cholestatic rats, the underlying mechanisms are unclear. Therefore, we examined the effects of a statin (simvastatin) on the expression of hepcidin, erythropoietin receptor (EPOR) and erythropoietin ... More
TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
Authors:Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y, Kelly K,
Journal:BMC Cancer
PubMed ID:18597688
'INTRODUCTION: Signaling downstream of Ras is mediated by three major pathways, Raf/ERK, phosphatidylinositol 3 kinase (PI3K), and Ral guanine nucleotide exchange factor (RalGEF). Ras signal transduction pathways play an important role in breast cancer progression, as evidenced by the frequent over-expression of the Ras-activating epidermal growth factor receptors EGFR and ... More
Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro.
Authors:Qian L, Berry EC, Fu JD, Ieda M, Srivastava D,
Journal:
PubMed ID:23722259
Cardiac fibroblasts can be reprogrammed to cardiomyocyte-like cells by the introduction of three transcription factors: Gata4, Mef2c and Tbx5 (collectively referred to here as GMT). Resident cardiac fibroblasts can be converted in vivo into induced cardiomyocyte-like cells (iCMs) that closely resemble endogenous cardiomyocytes and electrically integrate with the host myocardium. ... More